The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.

Programme

Livestream recordings

Presentations from 15.11.2021

Professor Dr Thomas Hartung, Johns Hopkins Bloomberg School of Public Health (JHSPH)
Recent advances in the field

Dr Anton Simeonov, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
High-throughput screening to advance in vitro toxicology

Dr Clemens Wittwehr, Joint Research Centre (JRC)
NAM-derived data in regulatory environments: Templates, AOPs and ontologies

Presentations from 16.11.2021

 

Professor Dr Roland Grafstroem, Karolinska Institute
Transcriptomics

Professor Dr Bob van de Water, Leiden University
High throughput transcriptomics (HHTr) applications in read across: EU-ToxRisk experience

Professor Dr Bennard van Ravenzwaay, BASF
Use of metabolomics for Read Across

Dr Wibke Busch, UFZ
Toxicogenomics with the zebrafish embryo model – from individual observations to comprehensive mixture predictions

Dr Oliver Poetz, Natural and Medical Science Institute (NMI), University of Tuebingen
Targeted Proteomics in Toxicology

Presentations from 17.11.2021

Dr Tomasz Sobanski, European Chemicals Agency (ECHA)
Experience of ECHA in applying NAMs in a regulatory context

Dr Pascal Sanders, Occupational Health & Safety (ANSES)
Current applications - a regulatory authority perspective

Dr Mirjam Luijten, National Institute for Public Health and the Environment (RIVM)
NAMs in chemical risk assessment: a new game requires new rules

Professor Dr Vera Rogiers, Scientific Committee on Consumer Safety (SCCS)
New methods, OMICS and novel concepts in risk assessment of cosmetic ingredients

Dr Toru Kawanishi, Food Safety Commission of Japan (FSCJ)
The perspective: Application of New Approach Methodologies to Food Risk Assessment by Food Safety Commission of Japan

Dr Weida Tong, United States Food and Drug Administration (US FDA)
AI for Regulatory Science at FDA